These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 35311705)

  • 21. Directional information flow in patients with Alzheimer's disease. A source-space resting-state MEG study.
    Engels MMA; Yu M; Stam CJ; Gouw AA; van der Flier WM; Scheltens P; van Straaten ECW; Hillebrand A
    Neuroimage Clin; 2017; 15():673-681. PubMed ID: 28702344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late combination shows that MEG adds to MRI in classifying MCI versus controls.
    Vaghari D; Kabir E; Henson RN
    Neuroimage; 2022 May; 252():119054. PubMed ID: 35247546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitive and reproducible MEG resting-state metrics of functional connectivity in Alzheimer's disease.
    Schoonhoven DN; Briels CT; Hillebrand A; Scheltens P; Stam CJ; Gouw AA
    Alzheimers Res Ther; 2022 Feb; 14(1):38. PubMed ID: 35219327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective impairment of hippocampus and posterior hub areas in Alzheimer's disease: an MEG-based multiplex network study.
    Yu M; Engels MMA; Hillebrand A; van Straaten ECW; Gouw AA; Teunissen C; van der Flier WM; Scheltens P; Stam CJ
    Brain; 2017 May; 140(5):1466-1485. PubMed ID: 28334883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain glutathione levels--a novel biomarker for mild cognitive impairment and Alzheimer's disease.
    Mandal PK; Saharan S; Tripathi M; Murari G
    Biol Psychiatry; 2015 Nov; 78(10):702-10. PubMed ID: 26003861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicenter Tract-Based Analysis of Microstructural Lesions within the Alzheimer's Disease Spectrum: Association with Amyloid Pathology and Diagnostic Usefulness.
    Teipel SJ; Kuper-Smith JO; Bartels C; Brosseron F; Buchmann M; Buerger K; Catak C; Janowitz D; Dechent P; Dobisch L; Ertl-Wagner B; Fließbach K; Haynes JD; Heneka MT; Kilimann I; Laske C; Li S; Menne F; Metzger CD; Priller J; Pross V; Ramirez A; Scheffler K; Schneider A; Spottke A; Spruth EJ; Wagner M; Wiltfang J; Wolfsgruber S; Düzel E; Jessen F; Dyrba M;
    J Alzheimers Dis; 2019; 72(2):455-465. PubMed ID: 31594223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain oscillatory patterns in mild cognitive impairment due to Alzheimer's and Parkinson's disease: An exploratory high-density EEG study.
    Polverino P; Ajčević M; Catalan M; Mazzon G; Bertolotti C; Manganotti P
    Clin Neurophysiol; 2022 Jun; 138():1-8. PubMed ID: 35349920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disease tracking markers for Alzheimer's disease at the prodromal (MCI) stage.
    Drago V; Babiloni C; Bartrés-Faz D; Caroli A; Bosch B; Hensch T; Didic M; Klafki HW; Pievani M; Jovicich J; Venturi L; Spitzer P; Vecchio F; Schoenknecht P; Wiltfang J; Redolfi A; Forloni G; Blin O; Irving E; Davis C; Hårdemark HG; Frisoni GB
    J Alzheimers Dis; 2011; 26 Suppl 3():159-99. PubMed ID: 21971460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resting-state oscillations reveal disturbed excitation-inhibition ratio in Alzheimer's disease patients.
    van Nifterick AM; Mulder D; Duineveld DJ; Diachenko M; Scheltens P; Stam CJ; van Kesteren RE; Linkenkaer-Hansen K; Hillebrand A; Gouw AA
    Sci Rep; 2023 May; 13(1):7419. PubMed ID: 37150756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MRI-based Alzheimer's disease-resemblance atrophy index in the detection of preclinical and prodromal Alzheimer's disease.
    Liu W; Au LWC; Abrigo J; Luo Y; Wong A; Lam BYK; Fan X; Kwan PWL; Ma HW; Ng AYT; Chen S; Leung EYL; Ho CL; Wong SHM; Chu WC; Ko H; Lau AYL; Shi L; Mok VCT;
    Aging (Albany NY); 2021 May; 13(10):13496-13514. PubMed ID: 34091443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electroencephalography-based classification of Alzheimer's disease spectrum during computer-based cognitive testing.
    Kim SK; Kim H; Kim SH; Kim JB; Kim L
    Sci Rep; 2024 Mar; 14(1):5252. PubMed ID: 38438453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Spontaneous electroencephalographic and magneto-encephalographic activity as a marker of Alzheimer's disease and mild cognitive impairment].
    Fernández A; Gil Gregorio P; Maestú F
    Rev Esp Geriatr Gerontol; 2012; 47(1):27-32. PubMed ID: 22099881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Network-level permutation entropy of resting-state MEG recordings: A novel biomarker for early-stage Alzheimer's disease?
    Scheijbeler EP; van Nifterick AM; Stam CJ; Hillebrand A; Gouw AA; de Haan W
    Netw Neurosci; 2022 Jun; 6(2):382-400. PubMed ID: 35733433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hippocampal and Amygdalar Morphological Abnormalities in Alzheimer's Disease Based on Three Chinese MRI Datasets.
    Wei Y; Huang N; Liu Y; Zhang X; Wang S; Tang X
    Curr Alzheimer Res; 2020; 17(13):1221-1231. PubMed ID: 33602087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of neural dynamics in mild cognitive impairment and Alzheimer's disease using wavelet turbulence.
    Poza J; Gómez C; García M; Corralejo R; Fernández A; Hornero R
    J Neural Eng; 2014 Apr; 11(2):026010. PubMed ID: 24608272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regional functional connectivity predicts distinct cognitive impairments in Alzheimer's disease spectrum.
    Ranasinghe KG; Hinkley LB; Beagle AJ; Mizuiri D; Dowling AF; Honma SM; Finucane MM; Scherling C; Miller BL; Nagarajan SS; Vossel KA
    Neuroimage Clin; 2014; 5():385-95. PubMed ID: 25180158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of Machine Learning to Arterial Spin Labeling in Mild Cognitive Impairment and Alzheimer Disease.
    Collij LE; Heeman F; Kuijer JP; Ossenkoppele R; Benedictus MR; Möller C; Verfaillie SC; Sanz-Arigita EJ; van Berckel BN; van der Flier WM; Scheltens P; Barkhof F; Wink AM
    Radiology; 2016 Dec; 281(3):865-875. PubMed ID: 27383395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
    Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
    Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Event-related synchronization of alpha activity in early Alzheimer's disease and mild cognitive impairment: an MEG study combining beamformer and group comparison.
    Kurimoto R; Ishii R; Canuet L; Ikezawa K; Azechi M; Iwase M; Yoshida T; Kazui H; Yoshimine T; Takeda M
    Neurosci Lett; 2008 Oct; 443(2):86-9. PubMed ID: 18634854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of Magnetoencephalography in the Early Stages of Alzheimer Disease.
    Maestú F; Fernández A
    Neuroimaging Clin N Am; 2020 May; 30(2):217-227. PubMed ID: 32336408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.